Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:ceased_operations |
2022
|
| gptkbp:CEO_(former) |
gptkb:William_Clark
|
| gptkbp:focus |
infectious diseases
immunotherapy cancer vaccines |
| gptkbp:founded |
2006
|
| gptkbp:founder |
gptkb:Robert_Paull
gptkb:Darren_E._Higgins |
| gptkbp:headquarters_location |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Genocea Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:listedOn |
gptkb:NASDAQ
|
| gptkbp:notableProduct |
gptkb:GEN-011
GEN-009 |
| gptkbp:platform |
gptkb:ATLAS
|
| gptkbp:status |
defunct
|
| gptkbp:stockSymbol |
gptkb:GNCA
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.genocea.com/
|
| gptkbp:bfsParent |
gptkb:David_Sinclair
|
| gptkbp:bfsLayer |
5
|